Kronos Bio Inc. (KRON)
NASDAQ: KRON
· Real-Time Price · USD
0.89
0.01 (1.14%)
At close: Jun 13, 2025, 3:36 PM
1.14% (1D)
| Bid | 0.89 |
| Market Cap | 54.42M |
| Revenue (ttm) | 9.19M |
| Net Income (ttm) | -64.48M |
| EPS (ttm) | -1.09 |
| PE Ratio (ttm) | -0.82 |
| Forward PE | -0.65 |
| Analyst | Hold |
| Ask | 0.9 |
| Volume | 335,737 |
| Avg. Volume (20D) | 773,625 |
| Open | 0.88 |
| Previous Close | 0.88 |
| Day's Range | 0.88 - 0.90 |
| 52-Week Range | 0.65 - 1.60 |
| Beta | 1.64 |
About KRON
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KRON
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for KRON stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+28.91%
Kronos Bio shares are trading higher after the com...
Unlock content with
Pro Subscription
1 month ago
-19.98%
Kronos Bio shares are trading lower after the company announced it will be acquired by Concentra Biosciences for $0.57 in cash per share plus a contingent value right.
